Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Slides:

Advertisements

Similar presentations

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Advertisements

Subchorionic hematomas are increased in early pregnancy in women taking low-dose aspirin Ashley Truong, B.S., M. Mercedes Sayago, M.D., William H. Kutteh,

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Age at menarche: a predictor of diminished ovarian function?

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Michael M. Alper, M.D. Fertility and Sterility

Hysterosalpingography with use of mobile C-arm fluoroscopy

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

Raoul Orvieto, M. D. , M. Sc. , Eduard Hod, M. D

Robot-assisted laparoscopy for infertility treatment: current views

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial

Temporal trends in clomiphene citrate use: a population-based study

Medical treatment of ectopic pregnancy: a committee opinion

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Live birth of twins derived from zona-free oocytes

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers Andrea.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Insurance mandates and trends in infertility treatments

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis Fung-Wei Chang, M.D.,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Oocyte cryopreservation

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Philipp Reif, M. D. , Wolfgang Schöll, M. D. , Philipp Klaritsch, M. D

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Subchorionic hematomas are increased in early pregnancy in women taking low-dose aspirin Ashley Truong, B.S., M. Mercedes Sayago, M.D., William H. Kutteh,

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Mohamed Fawzy, M. D. , Mohamed Y. AbdelRahman, M. D. , Mohamed H

Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist N. Rollene, M. Amols, S. Hudson,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Nanette L. Rollene,

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated.

János Urbancsek, M. D. , Ph. D. , Erik E. Hauzman, M. D. , Ana R

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Association of endometriosis with body size and figure

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin- releasing hormone agonist short regimen on alternate days and an antagonist.

Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.

Current evaluation of amenorrhea

Genetic evaluation procedures at sperm banks in the United States

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Murat Arslan, M.D.,

A simplified novel laparoscopic formation of neovagina for cases of Mayer-Rokitansky- Küster-Hauser syndrome Atef Mohammad Darwish, M.D. Fertility and.

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Ahmed Badawy, M.D., Aboubakr.

In vitro sildenafil citrate use as a sperm motility stimulant

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Evidence of absence or absence of evidence

Contact among families who share the same sperm donor

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)

Presentation transcript:

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome Ákos Várnagy, M.D., József Bódis, M.D., D.Sc., Zoltán Mánfai, M.D., Ferenc Wilhelm, M.D., Csaba Busznyák, M.D., Miklós Koppán, M.D., Ph.D. Fertility and Sterility Volume 93, Issue 7, Pages 2281-2284 (May 2010) DOI: 10.1016/j.fertnstert.2009.01.085 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Percentage of occurrence of ovarian hyperstimulation syndrome. The characteristics that defined the contingency table were statistically significantly related (P<.001). n: number of cases in each subgroup. G1A, group 1, aspirin treatment. G1–, group 1, without aspirin treatment. G2A, group 2, aspirin treatment. G2–, group 2, without aspirin treatment. Fertility and Sterility 2010 93, 2281-2284DOI: (10.1016/j.fertnstert.2009.01.085) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions